Tag: #weightloss

23andMe study finds common gene variants modestly affect weight loss and nausea on GLP‑1 drugs

A Nature paper by 23andMe links common DNA variants to small differences in weight loss and nausea on GLP‑1 drugs; the company released a consumer report.

#genetics, #glp1, #23andme, #weightloss, #semaglutide

Lilly’s daily GLP-1 pill beats Novo’s oral semaglutide in diabetes trial, but side effects drive more dropouts

A Phase 3 head-to-head study finds Lilly’s orforglipron lowered A1c and weight more than Rybelsus, with higher quit rates.

#diabetes, #glp1, #weightloss, #pharma, #clinicaltrials